Penumbra Inc (PEN)
Surgical & Medical Instruments & Apparatus · Healthcare · $12.5B
Intrinsic Value (Consensus)
$101.06
Current Price
$318.46
Margin of Safety
-68.3%
68.3% Above Intrinsic Value
Value: $101
Price: $318
Valuation Model Estimates
Current Price: $318.46
DCF (Discounted Cash Flow)
$209.11
Graham Number
$60.84
Earnings Power Value
$43.88
Relative Value (P/E)
$90.40
Dividend Discount Model
Not applicable
—
Consensus Value
$101.06
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
61
Profitability
18/25
Strength
17/25
Valuation
7/25
Growth
19/25
Financial Health Signals
Strong earnings growth (20% YoY)
Key Financials
- EPS (TTM)
- $4.52
- EPS (Forward)
- $5.42
- Book Value
- $36.39
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 12.4%
- Debt/Equity
- —
- Revenue Growth
- 17.5%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance